High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2

We use state-of-the-art computer-aided drug design (CADD) techniques to identify prospective inhibitors of the main protease enzyme, 3CL(pro) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19. From our screening of over one million compounds including approved drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Olubiyi, Olujide O., Olagunju, Maryam, Keutmann, Monika, Loschwitz, Jennifer, Strodel, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396980/
https://www.ncbi.nlm.nih.gov/pubmed/32668701
http://dx.doi.org/10.3390/molecules25143193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396980/
https://www.ncbi.nlm.nih.gov/pubmed/32668701
http://dx.doi.org/10.3390/molecules25143193

Ejemplares similares